Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients
- 1 June 1999
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nature Medicine
- Vol. 5 (6), 677-685
- https://doi.org/10.1038/9525
Abstract
We identified circulating CD8+ T-cell populations specific for the tumor-associated antigens (TAAs) MART-1 (27-35) or tyrosinase (368-376) in six of eleven patients with metastatic melanoma using peptide/HLA-A*0201 tetramers. These TAA-specific populations were of two phenotypically distinct types: one, typical for memory/effector T cells; the other, a previously undescribed phenotype expressing both naive and effector cell markers. This latter type represented more than 2% of the total CD8+ T cells in one patient, permitting detailed phenotypic and functional analysis. Although these cells have many of the hallmarks of effector T cells, they were functionally unresponsive, unable to directly lyse melanoma target cells or produce cytokines in response to mitogens. In contrast, CD8+ T cells from the same patient were able to lyse EBV-pulsed target cells and showed robust allogeneic responses. Thus, the clonally expanded TAA-specific population seems to have been selectively rendered anergic in vivo. Peptide stimulation of the TAA-specific T-cell populations in other patients failed to induce substantial upregulation of CD69 expression, indicating that these cells may also have functional defects, leading to blunted activation responses. These data demonstrate that systemic TAA-specific T-cell responses can develop de novo in cancer patients, but that antigen-specific unresponsiveness may explain why such cells are unable to control tumor growth.Keywords
This publication has 40 references indexed in Scilit:
- CD4+ T-cell memory, CD45R subsets and the persistence of antigen—a unifying conceptImmunology Today, 1998
- Intraepithelial Lymphocytes: Origins, Distribution, and FunctionCritical Reviews in Immunology, 1998
- Phenotypic and Functional Separation of Memory and Effector Human CD8+ T CellsThe Journal of Experimental Medicine, 1997
- Phenotypic Analysis of Antigen-Specific T LymphocytesScience, 1996
- Melanoma immunotherapy: new dreams or solid hopes?Immunology Today, 1996
- The cytokine microenvironment of human colon carcinoma: Lymphocyte expression of tumor necrosis factor-α and interleukin-4 predicts improved survivalCancer, 1996
- New treatment options for patients with melanoma: review of melanoma-derived T-cell epitope-based peptide vaccinesMelanoma Research, 1996
- A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas.The Journal of Experimental Medicine, 1994
- Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes.The Journal of Experimental Medicine, 1994
- Role of Bone Marrow-Derived Cells in Presenting MHC Class I-Restricted Tumor AntigensScience, 1994